138 related articles for article (PubMed ID: 15150563)
1. AUC of Calvert's formula in targeted intra-arterial carboplatin chemoradiotherapy for cancer of the oral cavity.
Oya R; Nakamura S; Ikemura K; Takagi S; Mugino H
Br J Cancer; 2004 Jun; 90(11):2062-6. PubMed ID: 15150563
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of expected AUC of carboplatin (CBDCA) predicted by Chatelut's formula in comparison with Calvert's].
Nakamura T; Onishi Y; Kono T; Maeda T; Wada T; Hatae M
Gan To Kagaku Ryoho; 1997 Mar; 24(5):579-83. PubMed ID: 9087291
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Calvert's formula for dosage adjustment of carboplatin in Japanese patients with hormone refractory prostate cancer.
Sato E; Yano I; Jiko M; Takahashi K; Motohashi H; Masuda S; Katsura T; Nishiyama H; Segawa T; Ito N; Kamoto T; Ogawa O; Inui K
Biol Pharm Bull; 2006 Jul; 29(7):1441-4. PubMed ID: 16819185
[TBL] [Abstract][Full Text] [Related]
4. Blood vessel density correlates with the effects of targeted intra-arterial carboplatin infusion with concurrent radiotherapy for squamous cell carcinomas of the oral cavity and oropharynx.
Takagi S; Inenaga R; Oya R; Nakamura S; Ikemura K
Br J Cancer; 2006 Jun; 94(11):1580-5. PubMed ID: 16670721
[TBL] [Abstract][Full Text] [Related]
5. Targeted intra-arterial carboplatin chemoradiotherapy and tegafur/uracil for oral and oropharyngeal cancer.
Oya R; Takagi S; Inenaga R; Nakamura S; Ikemura K; Onari N; Imada H; Korogi Y
J UOEH; 2006 Dec; 28(4):381-94. PubMed ID: 17209514
[TBL] [Abstract][Full Text] [Related]
6. Role of concomitant chemoradiation in locally advanced head and neck cancers.
Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
[TBL] [Abstract][Full Text] [Related]
7. Estimation of the area under the concentration-versus-time curve of carboplatin following irinotecan using a limited sampling model.
Asai G; Ando Y; Saka H; Ando M; Sugiura S; Sakai S; Hasegawa Y; Shimokata K
Eur J Clin Pharmacol; 1998; 54(9-10):725-7. PubMed ID: 9923575
[TBL] [Abstract][Full Text] [Related]
8. Adjustment of creatinine clearance improves accuracy of Calvert's formula for carboplatin dosing.
Ando Y; Minami H; Saka H; Ando M; Sakai S; Shimokata K
Br J Cancer; 1997; 76(8):1067-71. PubMed ID: 9376268
[TBL] [Abstract][Full Text] [Related]
9. Chemoradiation therapy using radiotherapy, systemic chemotherapy with 5-fluorouracil and nedaplatin, and intra-arterial infusion using carboplatin for locally advanced head and neck cancer - Phase II study.
Fuwa N; Kodaira T; Furutani K; Tachibana H; Nakamura T; Daimon T
Oral Oncol; 2007 Nov; 43(10):1014-20. PubMed ID: 17258494
[TBL] [Abstract][Full Text] [Related]
10. [Importance of AUC of carboplatin in head and neck cancer].
Shimizu T; Yoshida M; Makishima K
Nihon Jibiinkoka Gakkai Kaiho; 1998 Mar; 101(3):259-65. PubMed ID: 9584464
[TBL] [Abstract][Full Text] [Related]
11. Concurrent chemoradiotherapy with carboplatin and uracil-f tegafur (UFT) for patients with poor performance status with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
Katori H; Tsukuda M; Taguchi T
Acta Otolaryngol; 2007 Oct; 127(10):1099-104. PubMed ID: 17851890
[TBL] [Abstract][Full Text] [Related]
12. [Preoperative radiochemotherapy of advanced resectable cancer of the oral cavity with cisplatin vs paclitaxel/carboplatin. Analysis of two multimodality treatment concepts].
Eckardt A; Wegener G; Karstens JH
Mund Kiefer Gesichtschir; 2006 Jan; 10(1):30-6. PubMed ID: 16365743
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic study of carboplatin given on a 5-day intravenous schedule.
Ando Y; Minami H; Saka H; Ando M; Sugiura S; Sakai S; Shimokata K
Jpn J Cancer Res; 1997 May; 88(5):517-21. PubMed ID: 9247610
[TBL] [Abstract][Full Text] [Related]
14. Superselective cisplatin (CDDP)-carboplatin (CBDCA) combined infusion for head and neck cancers.
Imai S; Kajihara Y; Munemori O; Kamei T; Mori T; Handa T; Akisada K; Orita Y
Eur J Radiol; 1995 Dec; 21(2):94-9. PubMed ID: 8850500
[TBL] [Abstract][Full Text] [Related]
15. [Organ-preserving treatment in inoperable patients with primary oral and oropharyngeal carcinoma: chances and limitations].
Kovács AF; Eberlein K; Smolarz A; Weidauer S; Rohde S
Mund Kiefer Gesichtschir; 2006 May; 10(3):168-77. PubMed ID: 16604330
[TBL] [Abstract][Full Text] [Related]
16. [Simultaneous radiochemotherapy with taxol/carboplatin in advanced operable head-neck tumors. Preliminary results].
Eckardt A; Wildfang I; Karstens JH
Strahlenther Onkol; 1999 Oct; 175 Suppl 3():11-3. PubMed ID: 10554639
[TBL] [Abstract][Full Text] [Related]
17. Intra-arterial high-dose chemotherapy with cisplatin as part of a palliative treatment concept in oral cancer.
Rohde S; Kovács AF; Turowski B; Yan B; Zanella F; Berkefeld J
AJNR Am J Neuroradiol; 2005 Aug; 26(7):1804-9. PubMed ID: 16091533
[TBL] [Abstract][Full Text] [Related]
18. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
Zamboglou N; Pape H; Schnabel T; Wurm R; Bannach B; Fürst G; Schmitt G
Strahlenther Onkol; 1989 Sep; 165(9):647-51. PubMed ID: 2678546
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of area under the plasma-concentration-versus-time curve-based carboplatin plus standard-dose intravenous etoposide in elderly patients with small-cell lung cancer.
Okamoto H; Watanabe K; Nishiwaki Y; Mori K; Kurita Y; Hayashi I; Masutani M; Nakata K; Tsuchiya S; Isobe H; Saijo N
J Clin Oncol; 1999 Nov; 17(11):3540-5. PubMed ID: 10550152
[TBL] [Abstract][Full Text] [Related]
20. Combined radiotherapy and chemotherapy with carboplatin and UFT for head and neck squamous cell carcinoma.
Taguchi T; Ikeda Y; Mikami Y; Kawai S; Arai Y; Mochimatsu I; Tsukuda M
Anticancer Res; 2003; 23(1B):713-7. PubMed ID: 12680172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
